ARIPRA aripiprazole 10 mg tablet blister pack

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

aripiprazole, Quantity: 10 mg

MAH:

Medis Pharma Pty Ltd

INN:

aripiprazole

pharmaceutical_form:

Tablet, uncoated

composition:

Excipient Ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; maize starch; hyprolose

administration_route:

Oral

units_in_package:

30

prescription_type:

(S4) Prescription Only Medicine

therapeutic_indication:

Aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,Acute treatment of manic or mixed episodes associated with Bipolar I Disorder in adults as monotherapy and in combination with lithium or valproate;,Maintenance treatment of manic or mixed episodes in Bipolar I Disorder in adults as monotherapy.

leaflet_short:

Visual Identification: 8mm x 5 mm, capsule shaped, biconvex, white uncoated tablets with 10 debossed on one side and ZL on the other side; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

authorization_status:

Licence status A

authorization_date:

2014-10-29